Sumitomo Pharma Co., Ltd. (4506.T)
JPY 523.0
(0.97%)
JPY 523.0
(0.97%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 542.17 Billion JPY | 19.53% |
| 2022 | 453.6 Billion JPY | 32.37% |
| 2021 | 342.67 Billion JPY | 11.64% |
| 2020 | 306.95 Billion JPY | 13.76% |
| 2019 | 269.82 Billion JPY | -6.26% |
| 2018 | 287.83 Billion JPY | 8.08% |
| 2017 | 266.32 Billion JPY | 2.9% |
| 2016 | 258.8 Billion JPY | -1.14% |
| 2015 | 261.8 Billion JPY | 6.05% |
| 2014 | 246.86 Billion JPY | 2.24% |
| 2013 | 241.44 Billion JPY | 9.26% |
| 2012 | 220.99 Billion JPY | 75.22% |
| 2011 | 126.12 Billion JPY | -9.18% |
| 2010 | 138.87 Billion JPY | 80.64% |
| 2009 | 76.87 Billion JPY | 2.98% |
| 2008 | 74.65 Billion JPY | -40.18% |
| 2007 | 124.79 Billion JPY | 7.29% |
| 2006 | 116.31 Billion JPY | 34.53% |
| 2005 | 86.46 Billion JPY | 64.99% |
| 2004 | 52.4 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 57.78 Billion JPY | -1.78% |
| 2024 Q1 | 58.83 Billion JPY | -78.76% |
| 2023 Q3 | 80.76 Billion JPY | -1.5% |
| 2023 Q2 | 81.99 Billion JPY | -15.32% |
| 2023 Q1 | 96.82 Billion JPY | -16.05% |
| 2023 Q4 | 276.97 Billion JPY | 242.93% |
| 2023 FY | 542.17 Billion JPY | 19.53% |
| 2022 Q2 | 156.15 Billion JPY | 57.41% |
| 2022 Q1 | 99.2 Billion JPY | 14.47% |
| 2022 Q4 | 115.32 Billion JPY | 39.1% |
| 2022 FY | 453.6 Billion JPY | 32.37% |
| 2022 Q3 | 82.91 Billion JPY | -46.9% |
| 2021 Q4 | 86.66 Billion JPY | -0.05% |
| 2021 FY | 342.67 Billion JPY | 11.64% |
| 2021 Q1 | 84.41 Billion JPY | -19.24% |
| 2021 Q2 | 84.89 Billion JPY | 0.56% |
| 2021 Q3 | 86.7 Billion JPY | 2.14% |
| 2020 FY | 306.95 Billion JPY | 13.76% |
| 2020 Q1 | 74.61 Billion JPY | -14.83% |
| 2020 Q2 | 68.64 Billion JPY | -8.0% |
| 2020 Q3 | 59.16 Billion JPY | -13.81% |
| 2020 Q4 | 104.52 Billion JPY | 76.66% |
| 2019 FY | 269.82 Billion JPY | -6.26% |
| 2019 Q1 | 48.1 Billion JPY | -34.07% |
| 2019 Q2 | 59.37 Billion JPY | 23.42% |
| 2019 Q3 | 74.73 Billion JPY | 25.87% |
| 2019 Q4 | 87.6 Billion JPY | 17.23% |
| 2018 Q1 | 71.18 Billion JPY | 38.72% |
| 2018 FY | 287.83 Billion JPY | 8.08% |
| 2018 Q2 | 69.77 Billion JPY | -1.99% |
| 2018 Q3 | 73.9 Billion JPY | 5.93% |
| 2018 Q4 | 72.97 Billion JPY | -1.26% |
| 2017 FY | 266.32 Billion JPY | 2.9% |
| 2017 Q4 | 51.31 Billion JPY | -36.62% |
| 2017 Q3 | 80.96 Billion JPY | 40.04% |
| 2017 Q2 | 57.81 Billion JPY | -13.78% |
| 2017 Q1 | 67.04 Billion JPY | -6.73% |
| 2016 Q3 | 63.44 Billion JPY | 8.52% |
| 2016 Q1 | 65 Billion JPY | -3.59% |
| 2016 Q4 | 71.88 Billion JPY | 13.29% |
| 2016 FY | 258.8 Billion JPY | -1.14% |
| 2016 Q2 | 58.46 Billion JPY | -10.06% |
| 2015 FY | 261.8 Billion JPY | 6.05% |
| 2015 Q4 | 67.42 Billion JPY | 4.72% |
| 2015 Q3 | 64.39 Billion JPY | 2.77% |
| 2015 Q2 | 62.65 Billion JPY | -6.94% |
| 2015 Q1 | 67.33 Billion JPY | 2.57% |
| 2014 Q2 | 60.91 Billion JPY | 6.93% |
| 2014 Q3 | 63.34 Billion JPY | 4.0% |
| 2014 Q4 | 65.64 Billion JPY | 3.62% |
| 2014 FY | 246.86 Billion JPY | 2.24% |
| 2014 Q1 | 56.96 Billion JPY | -18.27% |
| 2013 Q3 | 58.22 Billion JPY | 0.07% |
| 2013 FY | 241.44 Billion JPY | 9.26% |
| 2013 Q2 | 58.18 Billion JPY | 5.15% |
| 2013 Q1 | 55.33 Billion JPY | -9.04% |
| 2013 Q4 | 69.7 Billion JPY | 19.71% |
| 2012 Q1 | 25.39 Billion JPY | -54.09% |
| 2012 Q2 | 24.93 Billion JPY | -1.83% |
| 2012 Q3 | 109.82 Billion JPY | 340.51% |
| 2012 Q4 | 60.83 Billion JPY | -44.61% |
| 2012 FY | 220.99 Billion JPY | 75.22% |
| 2011 Q1 | 25.27 Billion JPY | -60.42% |
| 2011 Q3 | 20.18 Billion JPY | -20.32% |
| 2011 Q4 | 55.32 Billion JPY | 174.07% |
| 2011 FY | 126.12 Billion JPY | -9.18% |
| 2011 Q2 | 25.33 Billion JPY | 0.22% |
| 2010 Q4 | 63.87 Billion JPY | 158.31% |
| 2010 FY | 138.87 Billion JPY | 80.64% |
| 2010 Q2 | 29.63 Billion JPY | 16.38% |
| 2010 Q1 | 25.46 Billion JPY | -0.25% |
| 2010 Q3 | 24.72 Billion JPY | -16.56% |
| 2009 FY | 76.87 Billion JPY | 2.98% |
| 2009 Q4 | 25.52 Billion JPY | 38.84% |
| 2009 Q3 | 18.38 Billion JPY | -3.02% |
| 2009 Q2 | 18.95 Billion JPY | 2.46% |
| 2009 Q1 | 18.5 Billion JPY | -12.71% |
| 2008 Q2 | 18.48 Billion JPY | 0.0% |
| 2008 Q4 | 21.19 Billion JPY | 4.09% |
| 2008 Q3 | 20.36 Billion JPY | 10.19% |
| 2008 FY | 74.65 Billion JPY | -40.18% |
| 2007 FY | 124.79 Billion JPY | 7.29% |
| 2006 FY | 116.31 Billion JPY | 34.53% |
| 2005 FY | 86.46 Billion JPY | 64.99% |
| 2004 FY | 52.4 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 43.63 Billion JPY | -1142.409% |
| Takeda Pharmaceutical Company Limited | 2618.18 Billion JPY | 79.292% |
| Shionogi & Co., Ltd. | 197.62 Billion JPY | -174.344% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.73 Billion JPY | -14410.784% |
| Nippon Shinyaku Co., Ltd. | 65.63 Billion JPY | -726.096% |
| Kaken Pharmaceutical Co., Ltd. | 29.02 Billion JPY | -1767.894% |
| Eisai Co., Ltd. | 533.01 Billion JPY | -1.719% |
| Morishita Jintan Co., Ltd. | 5.28 Billion JPY | -10164.578% |
| Hisamitsu Pharmaceutical Co., Inc. | 65.8 Billion JPY | -723.924% |
| Mochida Pharmaceutical Co., Ltd. | 46.26 Billion JPY | -1071.84% |
| Fuso Pharmaceutical Industries,Ltd. | 11.55 Billion JPY | -4592.937% |
| Nippon Chemiphar Co., Ltd. | 8.23 Billion JPY | -6486.188% |
| Tsumura & Co. | 48.8 Billion JPY | -1011.014% |
| Kissei Pharmaceutical Co., Ltd. | 33.32 Billion JPY | -1526.981% |
| Torii Pharmaceutical Co., Ltd. | 19.53 Billion JPY | -2675.119% |
| Towa Pharmaceutical Co., Ltd. | 63.73 Billion JPY | -750.657% |
| Fuji Pharma Co., Ltd. | 12.65 Billion JPY | -4183.598% |
| Zeria Pharmaceutical Co., Ltd. | 40.46 Billion JPY | -1239.872% |
| KYORIN Holdings, Inc. | 45.39 Billion JPY | -1094.35% |
| Taiko Pharmaceutical Co.,Ltd. | 4.15 Billion JPY | -12942.459% |
| Daito Pharmaceutical Co.,Ltd. | 5.94 Billion JPY | -9019.849% |
| SymBio Pharmaceuticals Limited | 5.22 Billion JPY | -10281.162% |
| MedRx Co., Ltd | 959 Million JPY | -56435.454% |
| Mizuho Medy Co.,Ltd. | 2.87 Billion JPY | -18766.602% |
| Solasia Pharma K.K. | 1.47 Billion JPY | -36632.724% |
| Modalis Therapeutics Corporation | 2.37 Billion JPY | -22770.165% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 24.16 Billion JPY | -2143.637% |
| Sawai Group Holdings Co., Ltd. | 35.43 Billion JPY | -1430.141% |
| Cyfuse Biomedical K.K. | 735.18 Million JPY | -73647.145% |
| Toho Holdings Co., Ltd. | 99.81 Billion JPY | -443.169% |
| Koa Shoji Holdings Co.,Ltd. | 2.25 Billion JPY | -23918.878% |